Amedisys, Inc.

120 articles about Amedisys, Inc.

• Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

  2/21/2024

  Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.

• Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis

  2/8/2024

  Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide.

• Amedisys Finds Answer Key in Medalogix Pulse

  12/28/2023

  Medalogix and Amedisys announced an expanded partnership with the implementation of Medalogix Pulse for Home Health patients.

• Amedisys Reports Third Quarter 2023 Financial Results

  10/24/2023

  Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.

• Amedisys Celebrates National Quality WeekHeld October 15-21, this Observance Shines a Light on Our Commitment to Quality Care

  10/18/2023

  Amedisys, Inc., a leading provider of home health, hospice and high-acuity care in the home, is proud to celebrate National Quality Week October 15-21, 2023.

• Amedisys Reports Second Quarter 2023 Financial Results

  7/26/2023

  Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.

• Option Care Health Confirms Termination of Merger Agreement with Amedisys

  6/26/2023

  Option Care Health, Inc. announced that it has terminated its previously announced agreement to combine with Amedisys, Inc.

• Amedisys and Optum to Combine, Advancing Value-Based Care for Patients 

  6/26/2023

  Amedisys, a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine.

• Option Care Health Reiterates Value Creation Opportunity of its Previously Announced Definitive Merger Agreement with Amedisys

  6/5/2023

  Option Care Health, Inc. filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4 containing a joint proxy statement/prospectus in connection with its proposed merger with Amedisys, Inc.

• Amedisys Announces Receipt of Unsolicited Proposal From Optum

  6/5/2023

  Amedisys, Inc. announced that on May 26, 2023, the Company received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share.

• AMEDISYS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND UPDATES 2023 GUIDANCE

  5/3/2023

  Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2023.

• Amedisys Announces First Quarter 2023 Earnings Release and Conference Call Date

  4/20/2023

  Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, will report results for the first quarter ended March 31, 2023, after the market closes on May 3, 2023.

• Amedisys Board Appoints Richard Ashworth as New President and Chief Executive Officer

  3/13/2023

  Amedisys, Inc., the leading provider of quality home health, hospice, and high-acuity care services, announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the Board of Directors.

• Amedisys and nVoq Present Outcomes from Speech Recognition Study at PALTC23 Conference

  3/9/2023

  nVoq Incorporated, the in-home healthcare industry's leading provider of HIPAA compliant speech recognition solutions, collaborated with Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, to present outcomes realized during a 2022 joint study of speech recognition impact on documentation quality at the PALTC23 conference in Tampa, Florida (March 9-12, 2023).

• Amedisys to Present at Multiple Healthcare Conferences in March

  3/9/2023

  Amedisys, Inc. today announced that Paul Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Acting Chief Operating Officer, Executive Vice President and Chief Financial Officer, will present at Oppenheimer’s 33rd Annual Healthcare Conference on March 14th at 10:00 a.m. ET.

• Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership With BlueCross BlueShield of Tennessee

  2/15/2023

  Amedisys, Inc. reported its financial results for the three-month period and year ended December 31, 2022.

• Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Dates

  1/30/2023

  Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the fourth quarter and year ended December 31, 2022, after the market closes on February 15, 2023.

• Amedisys to Present at the 41st Annual J.P. Morgan Healthcare Conference

  12/28/2022

  Amedisys, Inc., a leading provider of home health, hospice, personal care and high-acuity care, announced that Paul B. Kusserow, Chairman and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 8:15 p.m. ET.

• Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences

  12/13/2022

  Amedisys, Inc. has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.

• Amedisys to Present at Bank of America Securities Home Care Conference

  12/2/2022

  Amedisys, Inc., a leading provider of home health, hospice, personal care and high-acuity care, announced that Paul B. Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Chief Operating Officer, will present at the Bank of American Securities Home Care Conference on Tuesday, December 6 at 9 a.m. ET.